Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Cefuroxime Sodium Injection Market Growth 2022-2028

  • LP 4822461
  • 106 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Cefuroxime Sodium Injection will have significant change from previous year. According to our (LP Information) latest study, the global Cefuroxime Sodium Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cefuroxime Sodium Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Cefuroxime Sodium Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cefuroxime Sodium Injection market, reaching US$ million by the year 2028. As for the Europe Cefuroxime Sodium Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Cefuroxime Sodium Injection players cover Hikma, Sagent, Pfizer, and Teligent, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Cefuroxime Sodium Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

0.25g/vial

0.5g/vial

0.75g/vial

1.5g/vial

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Hikma

Sagent

Pfizer

Teligent

SteriMax

Fresenius Kabi

Aglobal Care

Guangzhou Baiyunshan Tianxin Pharmaceutical

Sinopharm Weiqida Pharmaceutical

Shanghai New Asia Pharmacetical

Harbin Pharmaceutical Group

Youcare Pharmaceutical Group

Weikang Pharmaceutical

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cefuroxime Sodium Injection Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Cefuroxime Sodium Injection by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Cefuroxime Sodium Injection by Country/Region, 2017, 2022 & 2028

2.2 Cefuroxime Sodium Injection Segment by Type

2.2.1 0.25g/vial

2.2.2 0.5g/vial

2.2.3 0.75g/vial

2.2.4 1.5g/vial

2.3 Cefuroxime Sodium Injection Sales by Type

2.3.1 Global Cefuroxime Sodium Injection Sales Market Share by Type (2017-2022)

2.3.2 Global Cefuroxime Sodium Injection Revenue and Market Share by Type (2017-2022)

2.3.3 Global Cefuroxime Sodium Injection Sale Price by Type (2017-2022)

2.4 Cefuroxime Sodium Injection Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Cefuroxime Sodium Injection Sales by Application

2.5.1 Global Cefuroxime Sodium Injection Sale Market Share by Application (2017-2022)

2.5.2 Global Cefuroxime Sodium Injection Revenue and Market Share by Application (2017-2022)

2.5.3 Global Cefuroxime Sodium Injection Sale Price by Application (2017-2022)

3 Global Cefuroxime Sodium Injection by Company

3.1 Global Cefuroxime Sodium Injection Breakdown Data by Company

3.1.1 Global Cefuroxime Sodium Injection Annual Sales by Company (2020-2022)

3.1.2 Global Cefuroxime Sodium Injection Sales Market Share by Company (2020-2022)

3.2 Global Cefuroxime Sodium Injection Annual Revenue by Company (2020-2022)

3.2.1 Global Cefuroxime Sodium Injection Revenue by Company (2020-2022)

3.2.2 Global Cefuroxime Sodium Injection Revenue Market Share by Company (2020-2022)

3.3 Global Cefuroxime Sodium Injection Sale Price by Company

3.4 Key Manufacturers Cefuroxime Sodium Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Cefuroxime Sodium Injection Product Location Distribution

3.4.2 Players Cefuroxime Sodium Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Cefuroxime Sodium Injection by Geographic Region

4.1 World Historic Cefuroxime Sodium Injection Market Size by Geographic Region (2017-2022)

4.1.1 Global Cefuroxime Sodium Injection Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Cefuroxime Sodium Injection Annual Revenue by Geographic Region

4.2 World Historic Cefuroxime Sodium Injection Market Size by Country/Region (2017-2022)

4.2.1 Global Cefuroxime Sodium Injection Annual Sales by Country/Region (2017-2022)

4.2.2 Global Cefuroxime Sodium Injection Annual Revenue by Country/Region

4.3 Americas Cefuroxime Sodium Injection Sales Growth

4.4 APAC Cefuroxime Sodium Injection Sales Growth

4.5 Europe Cefuroxime Sodium Injection Sales Growth

4.6 Middle East & Africa Cefuroxime Sodium Injection Sales Growth

5 Americas

5.1 Americas Cefuroxime Sodium Injection Sales by Country

5.1.1 Americas Cefuroxime Sodium Injection Sales by Country (2017-2022)

5.1.2 Americas Cefuroxime Sodium Injection Revenue by Country (2017-2022)

5.2 Americas Cefuroxime Sodium Injection Sales by Type

5.3 Americas Cefuroxime Sodium Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Cefuroxime Sodium Injection Sales by Region

6.1.1 APAC Cefuroxime Sodium Injection Sales by Region (2017-2022)

6.1.2 APAC Cefuroxime Sodium Injection Revenue by Region (2017-2022)

6.2 APAC Cefuroxime Sodium Injection Sales by Type

6.3 APAC Cefuroxime Sodium Injection Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Cefuroxime Sodium Injection by Country

7.1.1 Europe Cefuroxime Sodium Injection Sales by Country (2017-2022)

7.1.2 Europe Cefuroxime Sodium Injection Revenue by Country (2017-2022)

7.2 Europe Cefuroxime Sodium Injection Sales by Type

7.3 Europe Cefuroxime Sodium Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Cefuroxime Sodium Injection by Country

8.1.1 Middle East & Africa Cefuroxime Sodium Injection Sales by Country (2017-2022)

8.1.2 Middle East & Africa Cefuroxime Sodium Injection Revenue by Country (2017-2022)

8.2 Middle East & Africa Cefuroxime Sodium Injection Sales by Type

8.3 Middle East & Africa Cefuroxime Sodium Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Cefuroxime Sodium Injection

10.3 Manufacturing Process Analysis of Cefuroxime Sodium Injection

10.4 Industry Chain Structure of Cefuroxime Sodium Injection

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Cefuroxime Sodium Injection Distributors

11.3 Cefuroxime Sodium Injection Customer

12 World Forecast Review for Cefuroxime Sodium Injection by Geographic Region

12.1 Global Cefuroxime Sodium Injection Market Size Forecast by Region

12.1.1 Global Cefuroxime Sodium Injection Forecast by Region (2023-2028)

12.1.2 Global Cefuroxime Sodium Injection Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Cefuroxime Sodium Injection Forecast by Type

12.7 Global Cefuroxime Sodium Injection Forecast by Application

13 Key Players Analysis

13.1 Hikma

13.1.1 Hikma Company Information

13.1.2 Hikma Cefuroxime Sodium Injection Product Offered

13.1.3 Hikma Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Hikma Main Business Overview

13.1.5 Hikma Latest Developments

13.2 Sagent

13.2.1 Sagent Company Information

13.2.2 Sagent Cefuroxime Sodium Injection Product Offered

13.2.3 Sagent Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Sagent Main Business Overview

13.2.5 Sagent Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Cefuroxime Sodium Injection Product Offered

13.3.3 Pfizer Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Teligent

13.4.1 Teligent Company Information

13.4.2 Teligent Cefuroxime Sodium Injection Product Offered

13.4.3 Teligent Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Teligent Main Business Overview

13.4.5 Teligent Latest Developments

13.5 SteriMax

13.5.1 SteriMax Company Information

13.5.2 SteriMax Cefuroxime Sodium Injection Product Offered

13.5.3 SteriMax Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 SteriMax Main Business Overview

13.5.5 SteriMax Latest Developments

13.6 Fresenius Kabi

13.6.1 Fresenius Kabi Company Information

13.6.2 Fresenius Kabi Cefuroxime Sodium Injection Product Offered

13.6.3 Fresenius Kabi Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Fresenius Kabi Main Business Overview

13.6.5 Fresenius Kabi Latest Developments

13.7 Aglobal Care

13.7.1 Aglobal Care Company Information

13.7.2 Aglobal Care Cefuroxime Sodium Injection Product Offered

13.7.3 Aglobal Care Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Aglobal Care Main Business Overview

13.7.5 Aglobal Care Latest Developments

13.8 Guangzhou Baiyunshan Tianxin Pharmaceutical

13.8.1 Guangzhou Baiyunshan Tianxin Pharmaceutical Company Information

13.8.2 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Product Offered

13.8.3 Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business Overview

13.8.5 Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments

13.9 Sinopharm Weiqida Pharmaceutical

13.9.1 Sinopharm Weiqida Pharmaceutical Company Information

13.9.2 Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Product Offered

13.9.3 Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sinopharm Weiqida Pharmaceutical Main Business Overview

13.9.5 Sinopharm Weiqida Pharmaceutical Latest Developments

13.10 Shanghai New Asia Pharmacetical

13.10.1 Shanghai New Asia Pharmacetical Company Information

13.10.2 Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Product Offered

13.10.3 Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Shanghai New Asia Pharmacetical Main Business Overview

13.10.5 Shanghai New Asia Pharmacetical Latest Developments

13.11 Harbin Pharmaceutical Group

13.11.1 Harbin Pharmaceutical Group Company Information

13.11.2 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Product Offered

13.11.3 Harbin Pharmaceutical Group Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Harbin Pharmaceutical Group Main Business Overview

13.11.5 Harbin Pharmaceutical Group Latest Developments

13.12 Youcare Pharmaceutical Group

13.12.1 Youcare Pharmaceutical Group Company Information

13.12.2 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Product Offered

13.12.3 Youcare Pharmaceutical Group Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Youcare Pharmaceutical Group Main Business Overview

13.12.5 Youcare Pharmaceutical Group Latest Developments

13.13 Weikang Pharmaceutical

13.13.1 Weikang Pharmaceutical Company Information

13.13.2 Weikang Pharmaceutical Cefuroxime Sodium Injection Product Offered

13.13.3 Weikang Pharmaceutical Cefuroxime Sodium Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Weikang Pharmaceutical Main Business Overview

13.13.5 Weikang Pharmaceutical Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Cefuroxime Sodium Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Cefuroxime Sodium Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 0.25g/vial

Table 4. Major Players of 0.5g/vial

Table 5. Major Players of 0.75g/vial

Table 6. Major Players of 1.5g/vial

Table 7. Global Cefuroxime Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 8. Global Cefuroxime Sodium Injection Sales Market Share by Type (2017-2022)

Table 9. Global Cefuroxime Sodium Injection Revenue by Type (2017-2022) & ($ million)

Table 10. Global Cefuroxime Sodium Injection Revenue Market Share by Type (2017-2022)

Table 11. Global Cefuroxime Sodium Injection Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Cefuroxime Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 13. Global Cefuroxime Sodium Injection Sales Market Share by Application (2017-2022)

Table 14. Global Cefuroxime Sodium Injection Revenue by Application (2017-2022)

Table 15. Global Cefuroxime Sodium Injection Revenue Market Share by Application (2017-2022)

Table 16. Global Cefuroxime Sodium Injection Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Cefuroxime Sodium Injection Sales by Company (2020-2022) & (K Units)

Table 18. Global Cefuroxime Sodium Injection Sales Market Share by Company (2020-2022)

Table 19. Global Cefuroxime Sodium Injection Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Cefuroxime Sodium Injection Revenue Market Share by Company (2020-2022)

Table 21. Global Cefuroxime Sodium Injection Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Cefuroxime Sodium Injection Producing Area Distribution and Sales Area

Table 23. Players Cefuroxime Sodium Injection Products Offered

Table 24. Cefuroxime Sodium Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Cefuroxime Sodium Injection Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Cefuroxime Sodium Injection Sales Market Share Geographic Region (2017-2022)

Table 29. Global Cefuroxime Sodium Injection Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Cefuroxime Sodium Injection Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Cefuroxime Sodium Injection Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Cefuroxime Sodium Injection Sales Market Share by Country/Region (2017-2022)

Table 33. Global Cefuroxime Sodium Injection Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Cefuroxime Sodium Injection Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Cefuroxime Sodium Injection Sales by Country (2017-2022) & (K Units)

Table 36. Americas Cefuroxime Sodium Injection Sales Market Share by Country (2017-2022)

Table 37. Americas Cefuroxime Sodium Injection Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Cefuroxime Sodium Injection Revenue Market Share by Country (2017-2022)

Table 39. Americas Cefuroxime Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 40. Americas Cefuroxime Sodium Injection Sales Market Share by Type (2017-2022)

Table 41. Americas Cefuroxime Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 42. Americas Cefuroxime Sodium Injection Sales Market Share by Application (2017-2022)

Table 43. APAC Cefuroxime Sodium Injection Sales by Region (2017-2022) & (K Units)

Table 44. APAC Cefuroxime Sodium Injection Sales Market Share by Region (2017-2022)

Table 45. APAC Cefuroxime Sodium Injection Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Cefuroxime Sodium Injection Revenue Market Share by Region (2017-2022)

Table 47. APAC Cefuroxime Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 48. APAC Cefuroxime Sodium Injection Sales Market Share by Type (2017-2022)

Table 49. APAC Cefuroxime Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 50. APAC Cefuroxime Sodium Injection Sales Market Share by Application (2017-2022)

Table 51. Europe Cefuroxime Sodium Injection Sales by Country (2017-2022) & (K Units)

Table 52. Europe Cefuroxime Sodium Injection Sales Market Share by Country (2017-2022)

Table 53. Europe Cefuroxime Sodium Injection Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Cefuroxime Sodium Injection Revenue Market Share by Country (2017-2022)

Table 55. Europe Cefuroxime Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 56. Europe Cefuroxime Sodium Injection Sales Market Share by Type (2017-2022)

Table 57. Europe Cefuroxime Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 58. Europe Cefuroxime Sodium Injection Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Cefuroxime Sodium Injection Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Cefuroxime Sodium Injection Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Cefuroxime Sodium Injection Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Cefuroxime Sodium Injection Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Cefuroxime Sodium Injection Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Cefuroxime Sodium Injection Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Cefuroxime Sodium Injection Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Cefuroxime Sodium Injection Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Cefuroxime Sodium Injection

Table 68. Key Market Challenges & Risks of Cefuroxime Sodium Injection

Table 69. Key Industry Trends of Cefuroxime Sodium Injection

Table 70. Cefuroxime Sodium Injection Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Cefuroxime Sodium Injection Distributors List

Table 73. Cefuroxime Sodium Injection Customer List

Table 74. Global Cefuroxime Sodium Injection Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Cefuroxime Sodium Injection Sales Market Forecast by Region

Table 76. Global Cefuroxime Sodium Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Cefuroxime Sodium Injection Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Cefuroxime Sodium Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Cefuroxime Sodium Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Cefuroxime Sodium Injection Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Cefuroxime Sodium Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Cefuroxime Sodium Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Cefuroxime Sodium Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Cefuroxime Sodium Injection Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Cefuroxime Sodium Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Cefuroxime Sodium Injection Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Cefuroxime Sodium Injection Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Cefuroxime Sodium Injection Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Cefuroxime Sodium Injection Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Cefuroxime Sodium Injection Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Cefuroxime Sodium Injection Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Cefuroxime Sodium Injection Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Cefuroxime Sodium Injection Revenue Market Share Forecast by Application (2023-2028)

Table 94. Hikma Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 95. Hikma Cefuroxime Sodium Injection Product Offered

Table 96. Hikma Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Hikma Main Business

Table 98. Hikma Latest Developments

Table 99. Sagent Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 100. Sagent Cefuroxime Sodium Injection Product Offered

Table 101. Sagent Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. Sagent Main Business

Table 103. Sagent Latest Developments

Table 104. Pfizer Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 105. Pfizer Cefuroxime Sodium Injection Product Offered

Table 106. Pfizer Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Pfizer Main Business

Table 108. Pfizer Latest Developments

Table 109. Teligent Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 110. Teligent Cefuroxime Sodium Injection Product Offered

Table 111. Teligent Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Teligent Main Business

Table 113. Teligent Latest Developments

Table 114. SteriMax Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 115. SteriMax Cefuroxime Sodium Injection Product Offered

Table 116. SteriMax Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. SteriMax Main Business

Table 118. SteriMax Latest Developments

Table 119. Fresenius Kabi Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 120. Fresenius Kabi Cefuroxime Sodium Injection Product Offered

Table 121. Fresenius Kabi Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Fresenius Kabi Main Business

Table 123. Fresenius Kabi Latest Developments

Table 124. Aglobal Care Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 125. Aglobal Care Cefuroxime Sodium Injection Product Offered

Table 126. Aglobal Care Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Aglobal Care Main Business

Table 128. Aglobal Care Latest Developments

Table 129. Guangzhou Baiyunshan Tianxin Pharmaceutical Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 130. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Product Offered

Table 131. Guangzhou Baiyunshan Tianxin Pharmaceutical Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Guangzhou Baiyunshan Tianxin Pharmaceutical Main Business

Table 133. Guangzhou Baiyunshan Tianxin Pharmaceutical Latest Developments

Table 134. Sinopharm Weiqida Pharmaceutical Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 135. Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Product Offered

Table 136. Sinopharm Weiqida Pharmaceutical Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Sinopharm Weiqida Pharmaceutical Main Business

Table 138. Sinopharm Weiqida Pharmaceutical Latest Developments

Table 139. Shanghai New Asia Pharmacetical Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 140. Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Product Offered

Table 141. Shanghai New Asia Pharmacetical Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Shanghai New Asia Pharmacetical Main Business

Table 143. Shanghai New Asia Pharmacetical Latest Developments

Table 144. Harbin Pharmaceutical Group Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 145. Harbin Pharmaceutical Group Cefuroxime Sodium Injection Product Offered

Table 146. Harbin Pharmaceutical Group Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Harbin Pharmaceutical Group Main Business

Table 148. Harbin Pharmaceutical Group Latest Developments

Table 149. Youcare Pharmaceutical Group Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 150. Youcare Pharmaceutical Group Cefuroxime Sodium Injection Product Offered

Table 151. Youcare Pharmaceutical Group Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Youcare Pharmaceutical Group Main Business

Table 153. Youcare Pharmaceutical Group Latest Developments

Table 154. Weikang Pharmaceutical Basic Information, Cefuroxime Sodium Injection Manufacturing Base, Sales Area and Its Competitors

Table 155. Weikang Pharmaceutical Cefuroxime Sodium Injection Product Offered

Table 156. Weikang Pharmaceutical Cefuroxime Sodium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Weikang Pharmaceutical Main Business

Table 158. Weikang Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Cefuroxime Sodium Injection

Figure 2. Cefuroxime Sodium Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Cefuroxime Sodium Injection Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Cefuroxime Sodium Injection Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Cefuroxime Sodium Injection Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 0.25g/vial

Figure 10. Product Picture of 0.5g/vial

Figure 11. Product Picture of 0.75g/vial

Figure 12. Product Picture of 1.5g/vial

Figure 13. Global Cefuroxime Sodium Injection Sales Market Share by Type in 2021

Figure 14. Global Cefuroxime Sodium Injection Revenue Market Share by Type (2017-2022)

Figure 15. Cefuroxime Sodium Injection Consumed in Hospital

Figure 16. Global Cefuroxime Sodium Injection Market: Hospital (2017-2022) & (K Units)

Figure 17. Cefuroxime Sodium Injection Consumed in Clinic

Figure 18. Global Cefuroxime Sodium Injection Market: Clinic (2017-2022) & (K Units)

Figure 19. Cefuroxime Sodium Injection Consumed in Others

Figure 20. Global Cefuroxime Sodium Injection Market: Others (2017-2022) & (K Units)

Figure 21. Global Cefuroxime Sodium Injection Sales Market Share by Application (2017-2022)

Figure 22. Global Cefuroxime Sodium Injection Revenue Market Share by Application in 2021

Figure 23. Cefuroxime Sodium Injection Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Cefuroxime Sodium Injection Revenue Market Share by Company in 2021

Figure 25. Global Cefuroxime Sodium Injection Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Cefuroxime Sodium Injection Revenue Market Share by Geographic Region in 2021

Figure 27. Global Cefuroxime Sodium Injection Sales Market Share by Region (2017-2022)

Figure 28. Global Cefuroxime Sodium Injection Revenue Market Share by Country/Region in 2021

Figure 29. Americas Cefuroxime Sodium Injection Sales 2017-2022 (K Units)

Figure 30. Americas Cefuroxime Sodium Injection Revenue 2017-2022 ($ Millions)

Figure 31. APAC Cefuroxime Sodium Injection Sales 2017-2022 (K Units)

Figure 32. APAC Cefuroxime Sodium Injection Revenue 2017-2022 ($ Millions)

Figure 33. Europe Cefuroxime Sodium Injection Sales 2017-2022 (K Units)

Figure 34. Europe Cefuroxime Sodium Injection Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Cefuroxime Sodium Injection Sales 2017-2022 (K Units)

Figure 36. Middle East & Africa Cefuroxime Sodium Injection Revenue 2017-2022 ($ Millions)

Figure 37. Americas Cefuroxime Sodium Injection Sales Market Share by Country in 2021

Figure 38. Americas Cefuroxime Sodium Injection Revenue Market Share by Country in 2021

Figure 39. United States Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Cefuroxime Sodium Injection Sales Market Share by Region in 2021

Figure 44. APAC Cefuroxime Sodium Injection Revenue Market Share by Regions in 2021

Figure 45. China Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Cefuroxime Sodium Injection Sales Market Share by Country in 2021

Figure 52. Europe Cefuroxime Sodium Injection Revenue Market Share by Country in 2021

Figure 53. Germany Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Cefuroxime Sodium Injection Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Cefuroxime Sodium Injection Revenue Market Share by Country in 2021

Figure 60. Egypt Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Cefuroxime Sodium Injection Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Cefuroxime Sodium Injection in 2021

Figure 66. Manufacturing Process Analysis of Cefuroxime Sodium Injection

Figure 67. Industry Chain Structure of Cefuroxime Sodium Injection

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390